Description

4(3H)-Quinazolinone, 3-[2-Hydroxy-3-(1-Pyrrolidinyl)Propyl]-6,7,8-Trimethoxy-2-Methyl- is a sophisticated, multi-functional quinazolinone derivative of significant interest in advanced organic synthesis. This compound matters as a key pharmacologically active intermediate and a versatile building block for developing novel therapeutic agents. It is primarily needed by research institutions and pharmaceutical companies engaged in the discovery and development of new drugs, particularly those targeting central nervous system (CNS) disorders and other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, particularly for CNS-targeting therapies.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies to optimize biological activity and selectivity.
• Biochemical Tool Compound: Employed in vitro and in vivo to study specific biological pathways and receptor interactions.
• Contract Research & Development (CRO): Supplied to CROs and academic labs for custom synthesis projects and exploratory research programs.
• High-Purity Reference Standard: Provided as a certified reference material for analytical method development and quality control in pharmaceutical manufacturing.
• Preclinical Development: Utilized in the early-stage development of new chemical entities (NCEs) requiring this specific quinazolinone pharmacophore.

Basic Information

Product Name	4(3H)-Quinazolinone, 3-[2-Hydroxy-3-(1-Pyrrolidinyl)Propyl]-6,7,8-Trimethoxy-2-Methyl-
CAS No.	764585-86-6
Molecular Formula	C19H27N3O5
Molecular Weight	377.44 g/mol
Synonyms	3-[2-Hydroxy-3-(1-Pyrrolidinyl)Propyl]-6,7,8-Trimethoxy-2-Methyl-4(3H)-Quinazolinone; 2-Methyl-3-[2-hydroxy-3-(pyrrolidin-1-yl)propyl]-6,7,8-trimethoxyquinazolin-4(3H)-one; 6,7,8-Trimethoxy-2-methyl-3-[2-hydroxy-3-(pyrrolidin-1-yl)propyl]quinazolin-4(3H)-one; Quinazolinone derivative 764585-86-6; CAS 764585-86-6
EINECS	Contact for details

Quality Control

Our 4(3H)-Quinazolinone derivative is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.